Home/Filings/4/0001213900-21-007501
4//SEC Filing

Kidron Miriam 4

Accession 0001213900-21-007501

CIK 0001176309other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:31 PM ET

Size

5.5 KB

Accession

0001213900-21-007501

Insider Transaction Report

Form 4
Period: 2021-02-03
Kidron Miriam
DirectorChief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-03+100,000100,000 total
    Exercise: $10.40Exp: 2031-02-03Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest in 4 equal installments as follows: 25,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Documents

1 file

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001409232

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:31 PM ET
Size
5.5 KB